Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label single-arm phase 3 study of baloxavir marboxil in infants from birth to 1 year with influenza-like symptoms
MOH_2018-12-09_003615Phase 3Recruiting
- Sponsor
- Roche
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of baloxavir marboxil in influenza (3 arms), sponsored by Roche. Primary endpoints: Safety, Pharmacokinetics and 1 more. Started Dec 2018; status: recruiting.
02
Drugs
baloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on MOH_2018-12-09_003615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-12-09_003615.